APA (7th ed.) Citation

S, P., R, S., D, K., IM, R., N, S., CR, R., . . . DJ, P. (2021). Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy. The Journal of urology, 205(5), 1344. https://doi.org/10.1097/JU.0000000000001559

Chicago Style (17th ed.) Citation

S, Punnen, et al. "Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy." The Journal of Urology 205, no. 5 (2021): 1344. https://doi.org/10.1097/JU.0000000000001559.

MLA (9th ed.) Citation

S, Punnen, et al. "Heterogeneity in Genomic Risk Assessment from Tissue Based Prognostic Signatures Used in the Biopsy Setting and the Impact of Magnetic Resonance Imaging Targeted Biopsy." The Journal of Urology, vol. 205, no. 5, 2021, p. 1344, https://doi.org/10.1097/JU.0000000000001559.